Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changjun Yin

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
International Journal of Genomics|June 5, 2014
Association between NFKB1 -94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-AnalysisXiao Yang, Pengchao Li, Jun Tao, et al.
Plos One|December 7, 2013
Genetic variation in DROSHA 3'UTR regulated by hsa-miR-27b is associated with bladder cancer riskLin Yuan, Haiyan Chu, Meilin Wang, et al.
Plos One|May 8, 2014
Meta-analysis reveals a lack of association between UGT2B17 deletion polymorphism and tumor susceptibilityXiaheng Deng, Yidong Cheng, Xiao Yang, et al.
Mutagenesis|October 3, 2012
EGFR 3'UTR 774T>C polymorphism contributes to bladder cancer riskHaiyan Chu, Meilin Wang, Hua Jin, et al.
Chinese Medical Journal|July 3, 2014
Radiofrequency ablation versus partial nephrectomy for the treatment of clinical stage 1 renal masses: a systematic review and meta-analysisShangqian Wang, Chao Qin, Zhihang Peng, et al.
The Prostate|March 6, 2013
miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell linesChen Zhu, Jie Li, Qi Ding, et al.
BMC Urology|February 5, 2014
Retroperitoneal laparoscopic technique in treatment of complex renal stones: 75 casesChao Qin, Shangqian Wang, Pu Li, et al.
BMC Cancer|July 26, 2013
Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control studyJiawei Chen, Xinhai Cui, Hai Zhou, et al.
Cancer Cell|August 13, 2024
CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasisYifan Zhang, Guangjian Liu, Qianwen Zeng, et al.
Oncotarget|October 4, 2017
Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patientsGong Cheng, Shangqian Wang, Xiao Li, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
International Journal of Genomics|June 5, 2014
Association between NFKB1 -94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-AnalysisXiao Yang, Pengchao Li, Jun Tao, et al.
Plos One|December 7, 2013
Genetic variation in DROSHA 3'UTR regulated by hsa-miR-27b is associated with bladder cancer riskLin Yuan, Haiyan Chu, Meilin Wang, et al.
Plos One|May 8, 2014
Meta-analysis reveals a lack of association between UGT2B17 deletion polymorphism and tumor susceptibilityXiaheng Deng, Yidong Cheng, Xiao Yang, et al.
Mutagenesis|October 3, 2012
EGFR 3'UTR 774T>C polymorphism contributes to bladder cancer riskHaiyan Chu, Meilin Wang, Hua Jin, et al.
Chinese Medical Journal|July 3, 2014
Radiofrequency ablation versus partial nephrectomy for the treatment of clinical stage 1 renal masses: a systematic review and meta-analysisShangqian Wang, Chao Qin, Zhihang Peng, et al.
The Prostate|March 6, 2013
miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell linesChen Zhu, Jie Li, Qi Ding, et al.
BMC Urology|February 5, 2014
Retroperitoneal laparoscopic technique in treatment of complex renal stones: 75 casesChao Qin, Shangqian Wang, Pu Li, et al.
BMC Cancer|July 26, 2013
Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control studyJiawei Chen, Xinhai Cui, Hai Zhou, et al.
Cancer Cell|August 13, 2024
CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasisYifan Zhang, Guangjian Liu, Qianwen Zeng, et al.
Oncotarget|October 4, 2017
Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patientsGong Cheng, Shangqian Wang, Xiao Li, et al.
Pageof 18